183 related articles for article (PubMed ID: 2208792)
21. Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues.
Knowles DM; Tolidjian B; Marboe CC; Mittler RS; Talle MA; Goldstein G
Blood; 1984 Apr; 63(4):886-96. PubMed ID: 6423012
[TBL] [Abstract][Full Text] [Related]
22. Functional interaction between B cell subpopulations defined by CD23 expression.
Armitage RJ; Goff LK
Eur J Immunol; 1988 Nov; 18(11):1753-60. PubMed ID: 2974422
[TBL] [Abstract][Full Text] [Related]
23. [A study of lymphocyte subsets in human normal tonsil and lymph node].
Ge ZH; Lin ZQ; Wang RY
Shi Yan Sheng Wu Xue Bao; 1989 Mar; 22(1):75-85. PubMed ID: 2763767
[TBL] [Abstract][Full Text] [Related]
24. A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes.
Pulford K; Ralfkiaer E; MacDonald SM; Erber WN; Falini B; Gatter KC; Mason DY
Immunology; 1986 Jan; 57(1):71-6. PubMed ID: 3484721
[TBL] [Abstract][Full Text] [Related]
25. Cross-linking of surface IgM, but not surface IgD receptors, by soluble monoclonal antibodies primes murine B cells to secrete immunoglobulin in response to lymphokines.
Phillips C; Klaus GG
Eur J Immunol; 1993 Feb; 23(2):574-7. PubMed ID: 8436190
[TBL] [Abstract][Full Text] [Related]
26. The human gut contains a novel population of B lymphocytes which resemble marginal zone cells.
Spencer J; Finn T; Pulford KA; Mason DY; Isaacson PG
Clin Exp Immunol; 1985 Dec; 62(3):607-12. PubMed ID: 3910320
[TBL] [Abstract][Full Text] [Related]
27. CD1c antigens are present in normal and neoplastic B-cells.
Smith ME; Thomas JA; Bodmer WF
J Pathol; 1988 Oct; 156(2):169-77. PubMed ID: 3264333
[TBL] [Abstract][Full Text] [Related]
28. Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies.
Sánchez-Mateos P; Cebrián M; Acevedo A; López-Botet M; De Landázuri MO; Sánchez-Madrid F
Immunology; 1989 Sep; 68(1):72-9. PubMed ID: 2807372
[TBL] [Abstract][Full Text] [Related]
29. Oligoclonal development of germinal centre cells as detected by anti-idiotype antibodies.
De Jong D; Cramer G; Brand A; Kluin PM
Scand J Immunol; 1993 May; 37(5):602-4. PubMed ID: 8484106
[TBL] [Abstract][Full Text] [Related]
30. Cell surface phenotype of lymphoid cells from normal mice and mice treated with monoclonal anti-IgD from birth.
Skelly RR; Baine Y; Ahmed A; Xue B; Thorbecke GJ
J Immunol; 1983 Jan; 130(1):15-8. PubMed ID: 6600173
[TBL] [Abstract][Full Text] [Related]
31. Development of antigenic heterogeneity in the splenic meshwork of severe combined immunodeficient (SCID) mice after reconstitution with T and B lymphocytes.
Yoshida K; Matsuura N; Tamahashi N; Takahashi T
Cell Tissue Res; 1993 Apr; 272(1):1-10. PubMed ID: 8481947
[TBL] [Abstract][Full Text] [Related]
32. Fluorescence activated cell sorter analysis of murine B cell development.
Haaijman JJ; Boersma WJ
Adv Exp Med Biol; 1982; 149():103-9. PubMed ID: 6983208
[TBL] [Abstract][Full Text] [Related]
33. Human tonsil B lymphocyte function. I. The proliferative response to Staphylococcus aureus and pokeweed mitogen in relation to surface heavy chains mu and delta.
Mudde GC; Verberne CJ; Groeneveld K; De Gast GC
Clin Exp Immunol; 1984 Jun; 56(3):709-15. PubMed ID: 6430613
[TBL] [Abstract][Full Text] [Related]
34. T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution.
Jöhrens K; Shimizu Y; Anagnostopoulos I; Schiffmann S; Tiacci E; Falini B; Stein H
Haematologica; 2005 Aug; 90(8):1070-7. PubMed ID: 16079106
[TBL] [Abstract][Full Text] [Related]
35. Analysis of B-cell antigens in normal reactive lymphoid tissue using four B-cell monoclonal antibodies.
Hofman FM; Yanagihara E; Byrne B; Billing R; Baird S; Frisman D; Taylor CR
Blood; 1983 Oct; 62(4):775-83. PubMed ID: 6411151
[TBL] [Abstract][Full Text] [Related]
36. Distribution of B lymphocyte subsets in normal lymphoid tissue.
Murray LJ; Swerdlow SH; Habeshaw JA
Clin Exp Immunol; 1984 May; 56(2):399-406. PubMed ID: 6375918
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
38. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.
Press OW; Farr AG; Borroz KI; Anderson SK; Martin PJ
Cancer Res; 1989 Sep; 49(17):4906-12. PubMed ID: 2667754
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies to rat B lymphocyte (sub-)populations.
Kroese FG; Opstelten D; Wubbena AS; Deenen GJ; Aten J; Schwander EH; de Leij L; Nieuwenhuis P
Adv Exp Med Biol; 1985; 186():81-9. PubMed ID: 3901692
[No Abstract] [Full Text] [Related]
40. A cytotoxic monoclonal antibody detecting a novel B cell membrane antigen expressed predominantly on cells bearing surface membrane immunoglobulin.
Jephthah J; Terasaki PI; Hofman F; Wolde-Marian W; Peter JB; Billing R
Blood; 1984 Feb; 63(2):319-25. PubMed ID: 6607081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
